genedrive plc (LON:GDR – Get Free Report) reached a new 52-week high during mid-day trading on Tuesday after an insider bought additional shares in the company. The company traded as high as GBX 1.55 and last traded at GBX 1.40, with a volume of 10964131 shares. The stock had previously closed at GBX 1.40.
Specifically, insider Gino Miele bought 700,000 shares of the company’s stock in a transaction that occurred on Friday, August 28th. The shares were purchased at an average cost of GBX 1 per share, with a total value of £7,000.
genedrive Trading Up 0.1%
The company has a current ratio of 0.99, a quick ratio of 5.52 and a debt-to-equity ratio of -120.48. The company has a 50-day simple moving average of GBX 1.21 and a 200 day simple moving average of GBX 1.12. The firm has a market cap of £22.48 million, a PE ratio of -1.77 and a beta of 0.99.
About genedrive
genedrive plc is a pharmacogenetic testing company developing and commercialising a low cost, rapid, versatile and simple to use point of need pharmacogenetic platform for the diagnosis of genetic variants. This helps clinicians to quickly access key genetic information that will aid them make the right choices over the right medicine or dosage to use for an effective treatment, particularly important in time-critical emergency care healthcare paradigms. Based in the UK, the Company is at the forefront of Point of Care pharmacogenetic testing in emergency healthcare.
See Also
- Five stocks we like better than genedrive
- Is Abercrombie & Fitch’s Hot Streak Just Getting Started?
- Medtronic’s Stars Are Aligning for a Price Recovery
- Analysts See Major Upside for This Top-10 Performing S&P 500 Stock
- Cook Out, Silicon In: Will Ternus Trigger Apple’s Edge AI Boom?
Receive News & Ratings for genedrive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for genedrive and related companies with MarketBeat.com's FREE daily email newsletter.
